UNLIMITED TURBO LONG - IPSEN | Real-time Euronext Paris 07:19:29 18/06/2024 pm IST | ||
| 1.595 EUR | -7.27% |
|
| Current month | -0.58% | ||
| 1 month | +1.18% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 18/24/18 | 1.595 | -7.27% |
| 17/24/17 | 1.72 | 0.00% |
| 14/24/14 | 1.72 | -7.03% |
| 13/24/13 | 1.85 | -7.04% |
| 12/24/12 | 1.99 | +14.37% |
Real-time Euronext Paris
Last update June 18, 2024 at 07:19 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
BNP Paribas
|
| WU4EB | |
| ISIN | FRBNPP03GWZ3 |
| Date issued | 24/01/2022 |
| Strike | 87.93 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 0.16 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.415 € |
|---|---|
| Lowest since issue | 0.25 € |
| Spread | 0.01 € |
| Spread % | 0.63% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.4
EUR
Average target price
127.3
EUR
Spread / Average Target
+5.71%
- Stock Market
- Certificates
- WU4EB Certificat
